DE:9IB Stock Latest News
Company AnnouncementsIBT Secures FDA Pre-BLA Meeting for Breakthrough Neonatal Therapy1M ago
Company AnnouncementsInfant Bacterial Therapeutics Sets Nomination Committee Ahead of 2027 AGM1M ago
Company AnnouncementsInfant Bacterial Therapeutics Advances IBP-9414 Toward Market Despite Wider Losses2M ago- Pre-Earnings9IB Earnings this Week: How Will it Perform?2M ago
Company AnnouncementsInfant Bacterial Therapeutics Announces CFO Departure Amid Late-Stage Drug Push3M ago
Company AnnouncementsInfant Bacterial Therapeutics AGM Confirms Board, Withholds Dividend and Launches New Option Plan5M agoCompany AnnouncementsInfant Bacterial Therapeutics Advances Toward FDA Filing for IBP-9414 Amid Ongoing Losses5M ago
Company AnnouncementsInfant Bacterial Therapeutics Issues Corrected Notice for 2026 AGM in Stockholm7M ago
Company AnnouncementsInfant Bacterial Therapeutics Calls 2026 AGM With Focus on Governance, Capital and Incentives7M ago
Company AnnouncementsInfant Bacterial Therapeutics Advances IBP-9414 Toward Accelerated Approval7M ago
Company AnnouncementsIBT’s IBP-9414 Neonatal Trial Results Published in Leading Pediatric Journal8M ago- Company AnnouncementsInfant Bacterial Therapeutics Narrows Loss as FDA Backs Accelerated Path for IBP-94148M ago
Company AnnouncementsInfant Bacterial Therapeutics Partners with BioConnection for Drug Production10M agoCompany AnnouncementsInfant Bacterial Therapeutics Partners with Recipharm for IBP-9414 Production11M ago
Company AnnouncementsInfant Bacterial Therapeutics Advances IBP-9414 Amid Financial Challenges11M ago
Company AnnouncementsInfant Bacterial Therapeutics AB Forms Nomination Committee for 2026 AGM1y ago
Company AnnouncementsInfant Bacterial Therapeutics Advances Drug Registration for IBP-94141y ago
Company AnnouncementsIBT’s IBP-9414 Shows Promise in Reducing NEC Consequences1y ago
Company AnnouncementsInfant Bacterial Therapeutics Advances Toward Launch of Breakthrough Infant Drug1y ago